News

AlphaVax has completed process development and preclinical immunogenicity studies of its H1N1 (swine) influenza vaccine and will manufacture clinical trial material by the end of the month. The

The European Court of Justice (ECJ) has upheld the opinion Advocate General Kokott made in March, requiring registration of reacted monomers in polymers under REACh. The court said

BioCryst has reported positive results from two phase 3 studies of intravenous i.v. peramivir in patients with seasonal influenza. Shionogi conducted a three-armed, multi-center, randomized, double-blind, multi-national phase

Danisco and Turku University are behind the first study to demonstrate that dietary supplementation with probiotic cultures may relieve the symptoms of birch pollen allergy. Reportedly, a daily

Pfizer has received European Commission (EC) approval under the EU Merger Regulation the company’s pending acquisition of Wyeth. The Commission’s decision includes Pfizer’s commitment to divest certain animal

Bionovo has announced that a study of the gene regulation in multiple cell lines by several of their estrogen receptor beta (ERb) candidates, will be published in Public

Novartis has extended the Alnylam’s RNAi therapeutics collaboration for a fifth and final planned year, through October 2010. The alliance was initiated in October 2005, and is focused

Essilor has announced consolidated revenue of an estimated E1.66 billion for the six months ended June 30, 2009, representing a 9.4% increase over the first half of 2008.

With the October deadline to re-authorize the DHS chemical plant security rules looming large, US House and Senate committees have approved budget provisions extending the rules for another